IN8bio, Inc. (INAB) Misses Q4 EPS by 1c
Get Alerts INAB Hot Sheet
Join SI Premium – FREE
IN8bio, Inc. (NASDAQ: INAB) reported Q4 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07).
For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
- Tenon Medical (TNON) files $100M mixed shelf
- LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share